WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today released the following statement after the House passed H.R. 6703, the Lower Health Care Premiums for All Americans Act, a bill lowering health care costs and providing American citizens with more affordable coverage:
“Liberal politicians like Jon Ossoff want to continue giving handouts to Big Insurance and illegal… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA), a pharmacist by trade, today introduced a resolution recognizing October 2025 as American Pharmacists Month, honoring the hardworking health care professionals many communities rely on to provide safe, accessible, affordable, and beneficial patient care.
“The work that pharmacists do is vital to the health of not only our patients… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today celebrated the Food and Drug Administration’s (FDA) announcement that it has granted an accelerated approval for Stealth Biotherapeutics’ Barth syndrome treatment, Forzinity (elamipretide HC1).
This landmark decision comes after tireless advocacy from Rep. Carter, who sent a letter to FDA calling on it to approve the drug,… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA) and Morgan Griffith (R-VA) today released the following statement regarding a forthcoming Government Accountability Office (GAO) report on Vision Benefit Managers (VBMs):
“We’re happy to hear GAO is nearing completion of its work detailing the growing abuses of Vision Benefit Managers. Since GAO was first tasked with this project… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today celebrated the Food and Drug Administration’s (FDA) decision to accept for review the resubmission of the New Drug Application for Stealth Biotherapeutics’ Barth Syndrome treatment elamipretide, with the goal of reaching a decision by September 26, 2025.
This comes after Rep. Carter sent a letter advocating for the FDA to… Read more »
AUGUSTA – Rep. Earl L. “Buddy” Carter (R-GA) this week met with officials at Augusta University to discuss his advocacy for the Medical College of Georgia (MCG), including the $1 million he secured in FY23 to support the College’s Center for Digital Health.
From Left to Right: David Hess, MD, Dean of Medical College of Georgia; Rep. Buddy Carter (GA-01); and Matt Lyon, MD, Director… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today launched the American-Made Medicines Caucus, a group focused on promoting policies to onshore and friendshore pharmaceutical manufacturing, strengthen our economic and national security interests, and reduce America’s reliance on adversarial countries for essential medications.
The United States is dependent on imports for… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today introduced the FDA Modernization Act 3.0, alongside bipartisan colleagues Reps. Nanette Barragán (D-CA), Vern Buchanan (R-FL), Rosa DeLauro (D-CT), Diana Harshbarger (R-TN), and Troy Carter (D-LA), a bill directing the FDA to fully implement provisions intended to reduce unnecessary animal testing for drug… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Shomari C. Figures (D-AL), Michael Rulli (R-OH), and Kim Schrier, M.D. (D-WA) today introduced the Improving Care in Rural America Reauthorization Act of 2025, a bill extending critical programs that increase access to health care services in rural communities.
Rural residents often encounter barriers to accessing health care,… Read more »
WASHINGTON, D.C. – Rep. Earl L. "Buddy" Carter (R-GA), Chairman of the Subcommittee on Health, delivered the following opening statement at today’s hearing titled Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs.
… Read more »
